Your browser doesn't support javascript.
loading
Metabolic Messengers: tumour necrosis factor.
Sethi, Jaswinder K; Hotamisligil, Gökhan S.
Afiliación
  • Sethi JK; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK. j.sethi@soton.ac.uk.
  • Hotamisligil GS; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service (NHS) Foundation Trust, Southampton, UK. j.sethi@soton.ac.uk.
Nat Metab ; 3(10): 1302-1312, 2021 10.
Article en En | MEDLINE | ID: mdl-34650277
Tumour necrosis factor (TNF) is a classical, pleiotropic pro-inflammatory cytokine. It is also the first 'adipokine' described to be produced from adipose tissue, regulated in obesity and proposed to contribute to obesity-associated metabolic disease. In this review, we provide an overview of TNF in the context of metabolic inflammation or metaflammation, its discovery as a metabolic messenger, its sites and mechanisms of action and some critical considerations for future research. Although we focus on TNF and the studies that elucidated its immunometabolic actions, we highlight a conceptual framework, generated by these studies, that is equally applicable to the complex network of pro-inflammatory signals, their biological activity and their integration with metabolic regulation, and to the field of immunometabolism more broadly.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor de Necrosis Tumoral alfa Límite: Humans Idioma: En Revista: Nat Metab Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor de Necrosis Tumoral alfa Límite: Humans Idioma: En Revista: Nat Metab Año: 2021 Tipo del documento: Article